---
title: "Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288419668.md"
description: "Truist Financial analyst Danielle Brill maintained a Buy rating on Praxis Precision Medicines (PRAX) with a $616 price target. Deutsche Bank's David Hoang also issued a Buy rating today, while Wedbush maintained a Sell rating on the stock."
datetime: "2026-06-02T11:57:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288419668.md)
  - [en](https://longbridge.com/en/news/288419668.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288419668.md)
---

# Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial

Truist Financial analyst Danielle Brill maintained a Buy rating on Praxis Precision Medicines today and set a price target of $616.00.

### Claim 55% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

According to TipRanks, Brill is a 5-star analyst with an average return of 14.4% and a 54.72% success rate. Brill covers the Healthcare sector, focusing on stocks such as Biogen, Insmed, and Climb Bio.

In addition to Truist Financial, Praxis Precision Medicines also received a Buy from Deutsche Bank ‘s David Hoang in a report issued today. However, on the same day, Wedbush maintained a Sell rating on Praxis Precision Medicines (NASDAQ: PRAX).

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [CLYM.US](https://longbridge.com/en/quote/CLYM.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [Wedbush Analyst Ratings On PRAX, IDYA, EWTX, JADE](https://longbridge.com/en/news/288729852.md)
- [Praxis Precision's epilepsy drug misses main goal of mid-to-late stage study](https://longbridge.com/en/news/288333445.md)
- [Analysts Flood Cerebras Systems (CBRS) With Buy Calls](https://longbridge.com/en/news/289069074.md)
- [CICC Keeps Their Buy Rating on ZJLD Group, Inc. (6979)](https://longbridge.com/en/news/288951475.md)
- [Q2 EPS Estimates for Permian Resources Reduced by KeyCorp](https://longbridge.com/en/news/289003183.md)